NCT02536872

Brief Summary

The concept of organisms living on or in the human body without causing overt signs of an infection is common in medicine and has been termed a microbiome. Urine from patients with Overactive bladder (OAB) grows different organisms from controls without OAB. However, it is not known if the bacteria that have been identified are innocent commensals or pathogenic organism responsible for the symptoms of OAB. Previous data suggests that treatment with antibiotics does lead to an improvement in overactive bladder symptoms in a large number of patients. On this basis the investigators now treat are patients with similar antibiotic regimes. If antibiotics improve symptoms it would be expected that they would return the microbiome back to how it is in patients without OAB. This study aims to identify the effects of antibiotics on the urinary microbiome and to identify/confirm if antibiotic treatments cause improvement in OAB.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2015

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 24, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 1, 2015

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2015

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
Last Updated

October 17, 2016

Status Verified

October 1, 2016

Enrollment Period

11 months

First QC Date

August 24, 2015

Last Update Submit

October 13, 2016

Conditions

Keywords

infection overactive bladder

Outcome Measures

Primary Outcomes (1)

  • Change in bladder microbiology in patients treated with antibiotics.

    The number and type of different organisms will be quantified and compared to the pre treatment organisms

    6 weeks

Secondary Outcomes (5)

  • Change in the overactive bladder questionnaire (OAB-q) before and after treatment

    6 weeks

  • Change in Patient Perception of Bladder Condition (PPBC)

    6 weeks

  • To identify adherence to the treatment regime

    6 weeks

  • To identify adverse effects of the treatment

    6 weeks

  • Changes in symptoms using (change from baseline to assessment)

    6 weeks

Interventions

Eligibility Criteria

Age18 Years - 100 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

women with overactive bladder syndrome

You may qualify if:

  • \> age 18 years
  • Negative urine dipstick (nitrites) and culture (x10 to the power 5 colony forming units) x105 cfu
  • Idiopathic overactive bladder as per International Continence Society definition

You may not qualify if:

  • Patients treated with antibiotics for any infection within the last 6 weeks.
  • Patients with known multiple sclerosis, stroke, spinal injury, or other neurological disease
  • Urinary tract infection diagnosed by nitrite positivity or positive urine culture (x105 cfu)
  • Undiagnosed macroscopic or persistent microscopic haematuria needing investigation
  • Previous or current cancer of the urogenital tract.
  • Contraindication to multiple antibiotics
  • No suitable oral antibiotic regime
  • Patients unable to understand the study or complete the questionnaires.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medway Hospital

Gillingham, Kent, ME17 3AN, United Kingdom

Location

MeSH Terms

Interventions

Anti-Bacterial Agents

Intervention Hierarchy (Ancestors)

Anti-Infective AgentsTherapeutic UsesPharmacologic ActionsChemical Actions and Uses

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant Urogynaecologist

Study Record Dates

First Submitted

August 24, 2015

First Posted

September 1, 2015

Study Start

October 1, 2015

Primary Completion

September 1, 2016

Study Completion

October 1, 2016

Last Updated

October 17, 2016

Record last verified: 2016-10

Locations